CD8A and B-cell chronic lymphocytic leukemia: have observed a significantly high number of TIGIT+PD-1+CD8+ T cells (136), PD-1+TIM3+CD8 T cells (137), and PD-1+TIM3+CD4 T cells (138) in CLL patients compared with control, particularly in patients with advanced TNM stage.